Atlas Trials

HD-Idarubicin/Etoposide Intensified Conditioning Regimen Allo-HSCT for Adult ALL

Clinical trial NCT01873807 · UNKNOWN

Trial details

NCT number
NCT01873807
Sponsor
Nanfang Hospital, Southern Medical University
Status
UNKNOWN
Phase
Phase 4
Study type
INTERVENTIONAL
Acute Lymphoblastic Leukemia
Start date
2013-05-01
Primary completion
2015-12-01
Enrollment
100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.